Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries
Open Access
- 7 April 2022
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 8 (2) , e31461
Abstract
As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle–income countries for cancer care.Keywords
All Related Versions
This publication has 78 references indexed in Scilit:
- Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in KoreaJCO Clinical Cancer Informatics, 2018
- Global Survey of Clinical Oncology WorkforceJournal of Global Oncology, 2018
- Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor boardAnnals of Oncology, 2018
- Clinical experience with IBM Watson for Oncology (WFO) for multiple types of cancer patients in ChinaAnnals of Oncology, 2017
- Concordance study between IBM Watson for Oncology (WFO) and clinical practice for breast and lung cancer patients in ChinaAnnals of Oncology, 2017
- P1.01-069 Clinical Experience with IBM Watson for Oncology (WFO) Cognitive System for Lung Cancer Treatment in ChinaJournal of Thoracic Oncology, 2017
- Abstract S6-07: Double blinded validation study to assess performance of IBM artificial intelligence platform, Watson for oncology in comparison with Manipal multidisciplinary tumour board – First study of 638 breast cancer casesCancer Research, 2017
- Use of a cognitive computing system for treatment of cervical cancerJournal of Gynecologic Oncology, 2017
- The growing burden of cancer in India: epidemiology and social contextThe Lancet Oncology, 2014
- Cancer Control Opportunities in Low- and Middle-Income Countries2007